Which of the following is an indication for the use of raloxifene?: (A) Chronic renal failure, (B) Hypoparathyroidism, (C) Renal osteodystrophy, (D) Post-menopausal osteoporosis
Answer is D. -Raloxifene is a SERM used in post-menopausal osteoporosis. -It has additional advantage of causing decrease in risk of breast and endometrial cancer. -Major adverse effect of raloxifene is thromboembolism.